Gloria
González Aseguinolaza
Investigadora Senior
Hospital Universitario 12 de Octubre
Madrid, EspañaPublications in collaboration with researchers from Hospital Universitario 12 de Octubre (6)
2023
-
Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver
Molecular Genetics and Metabolism Reports, Vol. 35
2020
-
Brain ventricular enlargement in human and murine acute intermittent porphyria
Human molecular genetics, Vol. 29, Núm. 19, pp. 3211-3223
2018
-
Priming of dendritic cells by DNA-containing extracellular vesicles from activated T cells through antigen-driven contacts
Nature Communications, Vol. 9, Núm. 1
2016
-
Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria
Journal of Hepatology, Vol. 65, Núm. 4, pp. 776-783
2011
-
Sustained enzymatic correction by rAAV-mediated liver gene therapy protects against induced motor neuropathy in acute porphyria mice
Molecular Therapy, Vol. 19, Núm. 2, pp. 243-250
2010
-
Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria
Journal of Hepatology, Vol. 52, Núm. 3, pp. 417-424